Ulbig M, Kampik A, Thurau S, Landgraf R, Land W
Universitäts-Augenklinik, Würzburg, Federal Republic of Germany.
Graefes Arch Clin Exp Ophthalmol. 1991;229(3):242-5. doi: 10.1007/BF00167876.
This study reports the course of diabetic retinopathy in 25 patients (41 eyes, 9 one-eyed patients) who had undergone successful renal and pancreatic transplantation. The mean duration of follow-up was 38 months (range, 15-71 months). Visual acuity improved in 13 eyes (32%), remained stable in 19 (46%) and deteriorated in 9 (22%); only 2 of the latter 9 eyes (5%) sustained severe visual loss according to the definition of the Diabetic Retinopathy Study Group. The frequency and severity of vitreous hemorrhage improved in 19 eyes (46%), remained unchanged in 18 (44%) and worsened in 4 (10%). In comparison with other modes of treatment such as intensified conventional insulin therapy and artificial insulin-delivery systems, the combined renal and pancreatic transplantation seems to have advantages concerning the course of proliferative diabetic retinopathy.
本研究报告了25例(41只眼,9例单眼患者)成功接受肾胰联合移植患者的糖尿病视网膜病变病程。平均随访时间为38个月(范围15 - 71个月)。13只眼(32%)视力提高,19只眼(46%)视力稳定,9只眼(22%)视力下降;根据糖尿病视网膜病变研究组的定义,后9只眼中只有2只眼(5%)出现严重视力丧失。19只眼(46%)玻璃体积血的频率和严重程度改善,18只眼(44%)保持不变,4只眼(10%)加重。与强化常规胰岛素治疗和人工胰岛素输送系统等其他治疗方式相比,肾胰联合移植在增殖性糖尿病视网膜病变病程方面似乎具有优势。